First in Human Study of TORL-2-307-MAB in Participants With Advanced Cancer

Clinical trial NCT05159440 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT05159440
Sponsor: TORL Biotherapeutics, LLC
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Solid Tumor Gastric Cancer Pancreas Cancer Gastroesophageal Junction Adenocarcinoma

Start date: 2022-01-20
Primary completion: 2024-12-15
Enrollment: 70

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.